NIH-funded research U01 cooperative agreement

Understanding different types of diabetes and their progression over time

Official title: Longitudinal omics-based trajectories of type 2 diabetes subtypes: the T2D Heterogeneity Consortium

Funded at Massachusetts General Hospital · NIH-10974745 · Data updated 2026-11-12

This study is looking at different types of type 2 diabetes to find better ways to diagnose and treat it, so patients can get more personalized care that fits their unique needs.

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionMassachusetts General Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startSeptember 1, 2024
Project endAugust 31, 2029
Funding year2024
Award (this year)$823,473
NIH project number1U01DK140761-01
Project IDNIH-10974745 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include adults diagnosed with type 2 diabetes or those at risk of developing the condition.

Less likely to help

Patients with type 1 diabetes or those who do not have diabetes or prediabetes may not benefit from this research.

What this research studies

This research investigates the various subtypes of type 2 diabetes by analyzing clinical and multi-omic data to improve diagnosis and treatment. It aims to redefine how diabetes and prediabetes are classified, moving beyond traditional glucose and HbA1c measures. By integrating diverse data types, the study seeks to develop predictive models that can track disease progression and personalize treatment strategies for better patient outcomes. Patients may benefit from more accurate diagnoses and tailored therapies that address their specific diabetes subtype.

Why it matters

Potential benefit: If successful, this research could lead to more precise diagnoses and personalized treatment plans for individuals with type 2 diabetes.

How similar studies have gone: Previous research has shown promise in classifying diabetes subtypes using multi-omic approaches, indicating potential for success in this novel investigation.

Where this research is happening

  • Massachusetts General Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Manning, Alisa Knodle — Massachusetts General Hospital
  • Study coordinator: Manning, Alisa Knodle

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.